SEC Form D filing

Tango Therapeutics, Inc., 2025-10-28

An SEC Form D private-offering notice from Boston, MA, a $14,999,995 filer-stated offering target in Biotech. Filed 2025-10-28. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Tango Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing cancer medicines that exploit synthetic lethality, genetically targeted vulnerabilities in tumors.

Filed 2025-10-28Filed to raise $14,999,995First money in 2025-10-24Raised so far $14,999,995HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) Early
Source linked the Form D on EDGAR↗Website verified tangotx.com↗Named in the filing 9 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source